Target intelligence / Profile preview

Stratum corneum intercellular matrix protein (nonspecific; no singular canonical name)

Molecular classification
Other (refers to **structural and functional proteins of extracellular matrix**, not a single family), Structural protein, Lipid-associated protein
01

Overview

The **stratum corneum intercellular matrix** is a complex extracellular network found between terminally differentiated corneocytes in the skin’s outermost layer. It comprises organized **lipids (ceramides, cholesterol, sphingolipids)** and various **structural proteins** that together create the skin’s essential barrier against water loss, pathogens, and environmental insult. The matrix also contains enzymes and peptides that modulate barrier function, water retention, and innate immunity. Rather than a single molecule, this matrix represents a dynamic and heterogeneous mix of components crucial for cutaneous health and resilience[1][3][6]. **Key Point**: The queried entry is not a **discrete drug target** but rather refers broadly to the proteinaceous and lipid components of the stratum corneum extracellular matrix, making it an unsuitable or incorrect entry for structured drug-target databases. The stratum corneum’s barrier function is a pharmacologic endpoint, but the matrix proteins themselves do not represent a single, defined, druggable entity[1][3][6].

Other names
Stratum corneum matrix proteinsextracellular matrix proteins of stratum corneumSC intercellular proteins
02

Mechanism of action

Physical occlusion/restoration of barrier Enhancement of lipid or protein content in matrix Indirect modulation of hydration and barrier repair

03

Biological functions

Barrier functionWater retentionStructural integrityAntimicrobial defense
04

Disease associations

Inflammation (when dysfunctional, may increase susceptibility)Infection (disruption can predispose skin to pathogens)Other (e.g., atopic dermatitis, ichthyosis, other barrier disorders)
05

Safety considerations

Disruption (e.g., by excessive detergents, injury, or disease) can lead to increased skin permeability, dehydration, infection, or irritationNo drug-specific systemic side effects, as the matrix itself is not a druggable target
06

Interacting drugs

Emollients (e.g., glycerin, hyaluronic acid—though these act non-specifically)

2 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Corneometry (skin hydration)Lipid composition analysisFilaggrin breakdown products (specific to some matrix proteins)

Beyond the preview

Go deeper on Stratum corneum intercellular matrix protein (nonspecific; no singular canonical name).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum corneum intercellular matrix protein (nonspecific; no singular canonical name).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call